Clinical Trials Logo
  1. Home
  2. Central Nervous System
  3. NCT01527006

Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs

Central Nervous System Clinical Trial

Official title:
An Open-label Pilot Study With an Extension Phase to Evaluate the Pharmacokinetics, and to Generate Preliminary Safety, Tolerability, and Efficacy of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Pediatric Subjects From 2 to Less Than 12 Years of Age With Epilepsy

Clinical Trial Summary

This study is designed to evaluate the pharmacokinetics, efficacy, and safety of perampanel oral suspension on seizure frequency in pediatric participants maintained on one to three stable antiepileptic drugs

Clinical Trial Description

This is a multicenter, multiple ascending dose, open-label study (Core Study) with an Extension Phase. The Core Study consisted of 2 phases, the Pretreatment Phase and the Treatment Phase. The Pretreatment Phase lasted up to 2 weeks in duration, during which participants were assessed for their eligibility to participate in the study. The Treatment Phase consisted of 3 periods: Titration (7 weeks), Maintenance (4 weeks), and Follow-up (4 weeks; only for those participants not rolling over into the Extension Phase after completing the Treatment Phase and for those participants who discontinued from the study). All subjects who completed all scheduled visits up to and including the final visit of the Treatment Phase (Core Study) were eligible to participate in the Extension Phase of the study. The Extension Phase consisted of 2 periods: Maintenance (41 weeks) and Follow-up (4 weeks). ;

Study Design

Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01527006
Study type Interventional
Source Eisai Inc.
Contact
Status Completed
Phase Phase 2
Start date February 2012
Completion date April 2015
View Details
See also
  Status Clinical Trial Phase
Completed NCT04014491 - The Effects of Exercise Training on Corticospinal System in Overhead Athletes With Shoulder Impingement Syndrome N/A
Terminated NCT01006109 - Recording and Modulation of Neuronal Mechanisms During Operant Conditioning: a MEG Study
Recruiting NCT02559752 - Computer-based Neurocognitive Assessment in Children With Central Nervous System Tumors Receiving Proton Beam Radiation Therapy
Terminated NCT04644315 - A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors Phase 2
Completed NCT01531920 - A Study in Healthy Subjects to Determine the Effects When Alcohol is Administered With Perampanel Phase 1
Completed NCT02652260 - Effects of Switching From ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028) Phase 2
Recruiting NCT01541800 - Circulating microRNAs as Disease Markers in Pediatric Cancers N/A
Completed NCT02343718 - Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours Phase 1
Completed NCT03430427 - Brain Networks and Mobility Function: B-NET
Completed NCT03830762 - Xanamem™ in Healthy Elderly Subjects Phase 1
Completed NCT01517087 - Studying Motor Neuron Tests
Recruiting NCT05627986 - Sensorimotor Cortex Excitability in Shoulder Impingement Syndrome
Completed NCT01432288 - Touch and Attention MRI Study N/A
Completed NCT00067067 - Investigating Endothelial Precursor Cells (EPCs) N/A
Completed NCT03268239 - Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis Lesions N/A
Recruiting NCT04846764 - Rapid Declarative Neocortical Declarative Learning in Aging and Memory Diseases (ANéRAVIMM) N/A